A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 19:45
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
California turns to AI to help spot wildfires
Sony a7CR Review
Lattice Stock Tumbles. Like ON Semi, the Chip Maker Sees Weaker Auto Sales.
How We Test Password Managers
HP Labor Day Sale: Save Up to 67% on Laptops, Desktops, Monitors, More
PCMag Editorial Mission Statement
Twitter considers legal action over Threads app
Who is Trevor Zegras? Dixie D'Amelio rumored to be dating hockey player, Internet dubs TikTok star 'player'